Cargando…

Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program

IMPORTANCE: Branded products of multisource drugs are frequently dispensed in the Medicare Part D program, increasing costs for the program and patients. OBJECTIVE: To examine the reasons for dispensing branded multisource drugs in Medicare Part D. DESIGN, SETTING, AND PARTICIPANTS: This cross-secti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Socal, Mariana P., Bai, Ge, Anderson, Gerard F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926286/ https://www.ncbi.nlm.nih.gov/pubmed/33651110 http://dx.doi.org/10.1001/jamanetworkopen.2021.0483

Ejemplares similares

Branded prescription drug spending: a framework to evaluate policy options
por: Ballreich, Jeromie, et al.
Publicado: (2017)

Estimating Savings Opportunities From Therapeutic Substitutions of High-Cost Generic Medications
por: Socal, Mariana P., et al.
Publicado: (2022)

Association Between Waste-Free Formularies and Prescription Drug Spending Among Self-insured Employers
por: Socal, Mariana P., et al.
Publicado: (2021)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
por: Plummer, Elizabeth, et al.
Publicado: (2022)

The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional Study
por: Volpi, Connor, et al.
Publicado: (2020)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Prescriptions by Mail Improve Access and Affordability to Medications for Medicare Part D Beneficiaries
por: Frazee, Sharon Glave, et al.
Publicado: (2014)

Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
por: Eapen, Zubin J., et al.
Publicado: (2013)

Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
por: Liu, Judith, et al.
Publicado: (2022)

Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries
por: Maust, Donovan T., et al.
Publicado: (2020)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States
por: Wineinger, Nathan E., et al.
Publicado: (2019)

Correlation of antimicrobial prescription rate and county income in medicare part D
por: Volpi, Connor, et al.
Publicado: (2019)

The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics
por: Lester, Corey A., et al.
Publicado: (2016)

Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
por: Tisdale, Rebecca L., et al.
Publicado: (2021)

The impact of Medicare part D prescription drug benefit program on generic drug prescription: A study in long-term care facilities
por: Jung, Changmi, et al.
Publicado: (2019)

Medicare Support for Dental and Podiatry Graduate Medical Education Programs
por: Chen, Candice, et al.
Publicado: (2021)

Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
por: Lakdawalla, Darius, et al.
Publicado: (2021)

Patient Experiences in Selecting a Medicare Part D Prescription Drug Plan
por: Stults, Cheryl D, et al.
Publicado: (2017)

Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
por: Dickson, Sean, et al.
Publicado: (2023)

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement
por: Yala, Stella M, et al.
Publicado: (2014)

Medicare Quality Improvement Organizations' Ambulatory Drug Therapy Improvement Activities and Partnerships With Medicare Part D Prescription Drug Plans and Medicare Advantage Plans
por: Schulke, David G., et al.
Publicado: (2007)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022)

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
por: Park, Haesuk, et al.
Publicado: (2015)

A Comparison of Costs of Medicare Part D Prescriptions Dispensed at Retail and Mail Order Pharmacies
por: Carroll, Norman V.
Publicado: (2014)

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions
por: Lo-Ciganic, Wei-Hsuan, et al.
Publicado: (2019)

Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries
por: Hernandez, Inmaculada, et al.
Publicado: (2018)

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries
por: Sumarsono, Andrew, et al.
Publicado: (2020)

Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists
por: Dickson, Sean R., et al.
Publicado: (2023)

Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021)

Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017)

Comparison of Care Quality Metrics in 2-Sided Risk Medicare Advantage vs Fee-for-Service Medicare Programs
por: Cohen, Kenneth, et al.
Publicado: (2022)

Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020)

Use of High-Risk Medications Among Older Adults Enrolled in Medicare Advantage Plans vs Traditional Medicare
por: Figueroa, Jose F., et al.
Publicado: (2023)

Medicare Part D Coverage Gap Discount Program Beginning in 2011
por: Cahill, Judith A.
Publicado: (2010)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Affordability of Medical Care Among Medicare Enrollees
por: Madden, Jeanne M., et al.
Publicado: (2021)

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
por: Erath, Alexandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hdfs20s9pclohpjk02uhg1k49k